Login / Signup

Development and acceptability testing of a decision aid for considering whether to reduce antipsychotics in individuals with stable schizophrenia.

Yumi AokiYoshikazu TakaesuKentaro MatsuiTakahiro TokumasuHideaki TaniYoshiteru TakekitaTetsufumi KanazawaTaishiro KishimotoSeiichiro TarutaniNaoki HashimotoHiroyoshi TakeuchiKazuo MishimaKen Inada
Published in: Neuropsychopharmacology reports (2023)
A DA was successfully developed for schizophrenia, considering whether to reduce antipsychotics, which can be used in the SDM process.
Keyphrases
  • bipolar disorder
  • decision making